Posted inMedical Technology
Guardant blood test gives early warning of cancer progression in chemo patients, study finds
Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is…
Posted inBiotechnology
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed
Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS)…
Posted inBiotechnology
miR-770-5p Regulates KLF4/EGFR via PRMT5
In the rapidly evolving landscape of molecular oncology, a groundbreaking discovery has emerged that could redefine therapeutic strategies against several…
Posted inBiotechnology
New Genomic Tools Boost European Flax Breeding
In a remarkable leap forward for agricultural genomics, researchers have unveiled a comprehensive chromosome-scale assembly of the European flax, scientifically…
Posted inBiotechnology
AstraZeneca’s $1.3B bet reduces blood pressure by 14 mmHg over 12 weeks in phase 3 win
AstraZeneca's aldosterone synthase inhibitor baxdrostat reduced blood pressure by 14 mmHg over 12 weeks, the pharma has said in a…
Posted inBiotechnology
BM-MSC Exosomes Modulate TUG1, Fight Leukemia
In a groundbreaking study published in Medical Oncology, researchers have unveiled the promising therapeutic potential of bone marrow-derived mesenchymal stem…
Posted inBiotechnology
FDA puts Tenaya heart disease gene therapy clinical trial on hold
The FDA has put a clinical hold on a Tenaya Therapeutics gene therapy study while the biotech works to standardize activities…
Posted inBiotechnology
Evaluating Immunotherapy Response in Lung Cancer Patients
In recent years, the landscape of cancer treatment has been dramatically transformed by immunotherapy, offering new hope to patients with…
Posted inBiotechnology
Deregulation of NKX3.1 and AURKA in Prostate Cancer
In the evolving landscape of oncology, the intricate interactions between oncogenic pathways are gaining unprecedented attention. At the forefront of…
Posted inBiotechnology
Sphingolipid Metabolism: A Target in Triple-Negative Breast Cancer
In a groundbreaking study published in the Journal of Translational Medicine, researchers Li, Chen, and Wang lead an exploration into…